European Journal of Medicinal Chemistry (2020)
Update date:2022-08-29
Topics:
Liu, Junkai
Luo, Shanshan
Ma, Fenfen
Xu, Shengtao
Zhu, Yi Zhun
SCM-198 (Leonurine) has attracted great attention due to its cardioprotective effects in myocardial infarction (MI). However, no systematic modifications and structure-activity relationship (SAR) studies could be traced so far. In this study, 35 analogs of SCM-198 were designed, synthesized and their cardioprotective effects were evaluated. The cell viability assay on cardiomyocyte cell line H9c2 challenged with H2O2 showed that several analogs exhibited more potent cytoprotective effects than SCM-198 at 1 μM and 10 μM concentrations. LDH release level in cells treated with 1 μM 14o was comparable with cells treated with 10 μM SCM-198. Results of Bcl-2 expression and caspase-3 activation accordingly indicated higher protective activity of 14o than SCM-198. Moreover, in a mouse model of MI, the mice pretreated with 14o had much lower infarct size compared with that of SCM-198. The mechanism study suggested that 14o improved cardiac morphology and reduced apoptosis of cardiomyocytes in the border zone of infarction, as proved by H&E and TUNEL staining.
View MoreContact:+86-27-87204219, +86-27-87215023
Address:2402, HuiGu Space-time Building, 8 Forest Road, East Lake Hi-Tech Development Zone
Beijing ZhongDaXinHe Chemical Product Co.,Ltd
Contact:010-52876516
Address:tongzhoubeiyuan
Contact:13813902930 025-52714267
Address:20 Fengji Road, Yuhua Economic Development Zone, Nanjing, Jiangsu, P. R. China
Contact:+86-15527136576
Address:Wuhan city
Wuxi Pharma-Trading Import & Export Co.,Ltd.
Contact:+86-510-82304590 82716390
Address:Room 523,Youzu Alliance Building,No.88 Renmin Zhonglu,Wuxi,Jiangsu,China
Doi:10.1002/bbpc.19971011222
(1997)Doi:10.1002/anie.201911803
(2020)Doi:10.1134/S0023158410050046
(2010)Doi:10.1016/j.apcata.2014.09.048
(2015)Doi:10.1016/S0040-4039(02)01318-7
(2002)Doi:10.1002/anie.202009318
(2020)